Results 241 to 250 of about 1,602,934 (395)
Role of Humoral Antibodies in Resistance to Mycoplasma pneumoniae Pneumonia in Hamsters [PDF]
Eizo Hayatsu +5 more
openalex +1 more source
The Epidemiology of Primary Lateral Sclerosis: Results from a Population‐Based Cohort
Objective In this population‐based study, we described the epidemiology of primary lateral sclerosis (PLS) in northern Italy and compared the clinical characteristics of patients with PLS to those with predominant upper motor neuron (PUMN) involvement and classic amyotrophic lateral sclerosis (ALS).
Rosario Vasta +17 more
wiley +1 more source
Corticosteroids and hospital-acquired pneumonia. [PDF]
Pasqua LA, Cilloniz C, Torres A.
europepmc +1 more source
Vancomycin‐Functionalized Nanodelivery Systems for Antibacterial Tissue Engineering Scaffolds
This review consolidates recent advancements in VAN nanoformulations, critically evaluating their design principles, release mechanisms, and efficacy profiles against resistant Gram‐positive pathogens. While promising in vitro and in vivo results have been demonstrated, the clinicaltranslation of these technologies necessitates further rigorous ...
Nima Beheshtizadeh +5 more
wiley +1 more source
All patients operated for oesophageal cancer in Sweden from 2013 to April 2018 were identified, and 246 patients were recruited to this population‐based nationwide Swedish study. The results show that longitudinal health‐related quality of life after minimally invasive oesophagectomy was similar to that of the open surgical approach.
F. Klevebro +4 more
wiley +1 more source
Fast, Accurate Assignment of Clinical Diagnoses From Patient Notes by a Large Language Model: Critical Pediatric Pneumonia as a Use Case. [PDF]
Martin B +7 more
europepmc +1 more source
Antibacterial Applications of Black and Violet Phosphorus‐Based Biomaterials
Black and violet phosphorus‐based biomaterials exhibit broad‐spectrum antibacterial efficacy in various infections, including bone, skin, ocular, dental, lung, and sepsis cases. Their antibacterial mechanisms include physical disruption, light‐driven effects, targeted drug delivery, and enhanced composite strategies.
Zhuo Dai +8 more
wiley +1 more source
Harnessing breath biomarkers for pneumonia diagnosis and prognosis. [PDF]
Arnold CG +4 more
europepmc +1 more source
Statins and outcomes in patients with pneumonia [PDF]
Eric M. Mortensen +4 more
openalex +1 more source

